Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v5-FR Version v5-FR
Language French French
Date Updated 2024-02-05 2024-02-05
Drug Identification Number 02513803 02513803
Brand name SANDOZ DIMETHYL FUMARATE DELAYED-RELEASE CAPSULES SANDOZ DIMETHYL FUMARATE DELAYED-RELEASE CAPSULES
Common or Proper name DIMETHYL FUMARATE DELAYED-RELEASE CAPSULES DIMETHYL FUMARATE DELAYED-RELEASE CAPSULES
Company Name SANDOZ CANADA INCORPORATED SANDOZ CANADA INCORPORATED
Ingredients DIMETHYL FUMARATE DIMETHYL FUMARATE
Strength(s) 240MG 240MG
Dosage form(s) CAPSULE (DELAYED RELEASE) CAPSULE (DELAYED RELEASE)
Route of administration ORAL ORAL
Packaging size 56GRC 56GRC
ATC code L04AX L04AX
ATC description
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2023-12-19 2023-12-19
Estimated end date Unknown Unknown
Actual end date
Shortage status Actual shortage Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments